Flagstaff Hill, Australia

Gabriel Kremmidiotis

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gabriel Kremmidiotis

Introduction

Gabriel Kremmidiotis is a notable inventor based in Flagstaff Hill, Australia. He has made significant contributions to the field of biomedical research, particularly in the development of predictive biomarkers for cancer treatment. With a total of 13 patents to his name, Kremmidiotis continues to push the boundaries of innovation in healthcare.

Latest Patents

Among his latest patents, Kremmidiotis has developed biological markers such as SAP, SHBG, Myoglobin, MMP-9, and SCF. These markers are predictive of patient responses to treatment with vascular disrupting agents, specifically for cancer patients. Additionally, he has patented predictive baseline biomarkers, including Ferritin and IL-8, which also indicate patient responses to vascular disrupting agents. His work focuses on improving treatment methods for cancer patients, showcasing his commitment to advancing medical science.

Career Highlights

Kremmidiotis is currently associated with Bionomics Inc., where he applies his expertise in developing innovative solutions for cancer treatment. His career is marked by a dedication to research and a passion for improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, Kremmidiotis has collaborated with esteemed colleagues such as Jason Hugh Chaplin and Damian Wojciech Grobelny. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

Gabriel Kremmidiotis stands out as a prominent inventor in the field of biomedical research. His innovative work on predictive biomarkers for cancer treatment has the potential to significantly impact patient care. Through his patents and collaborations, he continues to contribute to the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…